You've just wrapped up a promising meeting with a potential biotech partner. Your science is solid, your data compelling. But when they ask for a leave-behind, you hand over a generic PDF thrown together in PowerPoint.
In biotech, sales collateral signals scientific credibility and readiness to partner. It carries real weight in a space where procurement cycles are long and the cost of a wrong vendor decision is enormous. So what does it actually cost to get it right? We break down every step using an 8–12 page product brochure as a reference example.
Generic templates and general branding agencies often miss the mark in biotech. Your audience whether a CRO procurement director, pharma R&D lead, HCP, or investor is scientifically trained and sceptical of oversimplification. Your collateral needs to be accurate enough for an expert, accessible enough for a generalist, and visually polished throughout.
The costs below reflect that brief.
Every piece of effective sales collateral starts with a clear brief. For biotech companies, this phase is especially important because the decision of what to communicate and to whom is rarely straightforward.
In this phase, you'll work through:
Typical costs for concept and strategy: From €2,000 more for complex multi-stakeholder products or where a full content architecture needs to be developed.
Speaking of sales collaterals, with conference-season upon us all, take a look at how you can not only create but also present a scientific poster.
This is where the substance of the collateral takes shape. For biotech companies, content development typically involves several distinct work streams:
Biotech collateral lives or dies by the quality of its copy. Generic marketing language about "innovative solutions" does nothing for a scientific buyer. What works is clear, precise language that conveys mechanism, differentiates your approach, and builds confidence without overclaiming.
Depending on the piece, copy may need to be reviewed by medical affairs or legal before it can be finalised. Plan for this in your timeline.
If your internal teams provide detailed briefing notes or draft text, a specialist scientific writer can shape and refine this into final copy. If starting from scratch, expect more time and cost.
In life science marketing, complex scientific concepts often need to be visualised: mechanisms of action, assay workflows, platform architectures, clinical study designs. These are not stock-photo jobs. Well-executed scientific illustrations and data visualisations are a significant investment, but they do the heavy lifting in communicating what makes your approach distinctive.
For photography, consider whether you have existing lab or facility imagery, or whether a professional shoot is needed. A half or full-day photography session is typically calculated at around €1,000 per day, with model fees and studio hire billed separately. Imagery commissioned this way can be reused across campaigns, websites, and trade show materials making it a worthwhile investment.
Stock images from image agency portals generally cost between €20 and €250 per image, depending on usage rights and exclusivity.
Data tables, competitive positioning matrices, and process flowcharts are frequently used in biotech collateral. These need to be accurate and clearly designed not decorative.
Typical costs for content development: from €2,000 but can be considerably higher depending on page count, the complexity of scientific illustrations required, and whether copy is being developed from scratch.
Once content is approved, the design phase brings everything together visually. For a life science company, design is not just about aesthetics. It communicates brand positioning and directly influences how credible and trustworthy a potential partner perceives you to be.
The design review process for biotech clients often involves multiple rounds of stakeholder input. Having a clear approval process in place saves time and budget.
Design and layout costs are typically included within the overall project estimate rather than broken out separately for shorter documents.
Once all content and design is approved, the agency produces a production-ready file — typically a press-ready PDF. This step includes:
Final proofreading and copy-editing
Preflight checks for print production
If required: a separate, optimised digital/screen version for download or email distribution
Optional: an interactive PDF version with embedded links and navigation
Typical costs for artwork and final repro: from €800
Print decisions for biotech collateral are worth thinking through carefully. For conference and partner environments, print quality matters. A flimsy brochure at a partnering event is a brand signal you don't want to send.
Key decisions include:
Paper weight and finish
Binding
Quantity
Sustainability
As a general benchmark, print production accounts for roughly one-fifth of total project costs.
Typical print production costs for an 8–12 page brochure with 4-page cover: from €400–500
There's a meaningful difference between an agency that produces attractive layouts and one that understands the regulatory landscape, scientific vocabulary, and communication dynamics of biotech. Canva templates and generalist studios won't convey the precision that life science buyers expect. Done well, sales collateral isn't just a leave-behind, it's a positioning tool and trust signal every time it changes hands.
A solid 8 to 12-page product brochure starts from around €5,500, with costs varying based on content complexity, illustration needs, and print spec. The assets you commission photography, scientific illustrations, core copy can be reused across your website, investor materials, and conference collateral, making the investment go further than it first appears.
If you're planning sales collateral and would like to discuss scope and budget, we're happy to talk through your project.